Abstract
Rice stripe mosaic virus (RSMV) belongs to the Cytorhabdovirus species in the Rhabdoviridae family. Recently, RSMV was widely spread in East Asia and caused severe yield losses. RSMV is transmitted by the planthopper vectors, Recilia dorsalis, Nephotettix virescens, and Nilaparvata lugens, that mostly affect rice. The adult vectors can hibernate, transmit the virus, lay eggs on rice plants, and, finally, multiply in subsequent generations, resulting in new infection outbreaks. RSMV-infected rice varieties display striped mosaicism, mild dwarfism, stiff and twisted leaves, delayed heading, short panicles with large unfilled grains, and yield reduction. In nature, the infection of multiple pathogens in the same host is widespread, which is defined as co-infection. It can be antagonistic or synergistic. Pathological synergistic effects between RSMV and other viruses can generate strains with new genetic characteristics, leading to unpredictable epidemiological consequences. After the first identification of RSMV in 2015, significant advancements in understanding the disease’s characteristics, symptoms, cycles, geographic distribution, potential vectors, and synergistic interaction, as well as its management strategies, were developed. To reduce the damage due to RSMV infection, many scientists have recommended pest control techniques to target adult vectors. It is also essential to confirm the actual time of monitoring, development of resistant varieties, and changes in cultivation systems. Due to the limitations of the conventional plant disease control technologies, improvements in efficiency and safety are in high demand. Therefore, to find efficient and environmentally safe controls to mitigate these challenges, reviews of research are the foremost step. In this review, we summarize the basic epidemiological information about the origin of RSMV and its infection symptoms in the field, synergistic interaction with viruses during co-transmission, yield losses, formulation of the disease cycle, and control strategies from several case studies. Finally, we recommend the formulation of the disease cycle and management strategies of RSMV infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.